The Valley Desk

Healthcare research from Bristol Myers Squibb, page 5

A filtered view. Show the full list.

Refine

280 publications and 1 clinical study · listings 97–120

Listings

  1. ArticleClinical therapeutics

    Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: Analysis of Number Needed To Treat and Number Needed To Harm

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  2. ArticleEClinicalMedicine

    Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  3. Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)

    Prognostic value of patient-reported outcomes in advanced or metastatic melanoma patients treated with immunotherapy: Findings from the CheckMate-067 study

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  4. ArticleEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

    Effect of light source and UVA quotient on monoclonal antibody stability during ambient light exposure studies

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Biomedical and life sciencesAdded

  5. ArticleESMO open

    Pharmacodynamic activity of BMS-986156, a glucocorticoid-induced TNF receptor-related protein agonist, alone or in combination with nivolumab in patients with advanced solid tumors

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  6. ArticleESMO open

    Risk profiles and incidence of cardiovascular events across different cancer types

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  7. ArticleESMO open

    Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  8. ArticleJACC. Advances

    Apixaban and Limiting Aspirin for Patients With Atrial Fibrillation, Percutaneous Coronary Intervention, and Multimorbidity

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  9. ArticleJACC. Basic to translational science

    Proteome-Wide Genetic Investigation of Large Artery Stiffness

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source

    Disease researchAdded

  10. Clinical trial reportJournal of the American College of Cardiology

    Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  11. Clinical trial reportJournal of the American College of Cardiology

    Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Public healthAdded

  12. Clinical trial reportJACC. Clinical electrophysiology

    Atrial Fibrillation Burden on a 14-Day ECG Monitor: Findings From the GUARD-AF Trial Screening Arm

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Public healthAdded

  13. ArticleJournal of lipid research

    Evaluation of antisense oligonucleotide therapy targeting Hsd17b13 in a fibrosis mice model

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  14. ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

    Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Research dataAdded

  15. ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

    Assessing the Content Validity of Preference-Based Measures in Cancer

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  16. ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

    A Methodological Study to Compare Alternative Modes of Administration With Value EQ-5D Using Preference-Elicitation Techniques

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  17. ArticleLeukemia research

    Incidence of second primary malignancies in relapsed/refractory B-cell non-Hodgkin's lymphoma patients in England

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Public healthAdded

  18. Clinical trial reportLeukemia research

    Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  19. ReviewMatrix biology : journal of the International Society for Matrix Biology

    The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseases

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded

  20. ArticleMultiple sclerosis and related disorders

    Comparative efficacy and safety of ozanimod and ponesimod for relapsing multiple sclerosis: A matching-adjusted indirect comparison

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  21. ReviewMolecular therapy. Methods & clinical development

    Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  22. ArticleThrombosis research

    Trends and factors associated with outpatient anticoagulant treatment initiation among VTE patients with active cancer

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  23. ArticleThrombosis research

    Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Clinical careAdded

  24. Clinical trial reportCell reports. Medicine

    Pharmacodynamic changes in tumor and immune cells drive iberdomide's clinical mechanisms of activity in relapsed and refractory multiple myeloma

    Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

    Disease researchAdded